Long-term seizure control outcomes after resection of gangliogliomas
- PMID: 22353798
- DOI: 10.1227/NEU.0b013e3182500a4c
Long-term seizure control outcomes after resection of gangliogliomas
Abstract
Background: Gangliogliomas are rare glioneuronal tumors that typically cause refractory seizures during the first 3 decades of life.
Objective: To determine the prognosticators of seizure outcome after surgery for ganglioglioma.
Methods: We reviewed the cases of 66 patients who underwent resection of gangliogliomas at the University of California, San Francisco. Demographic, seizure history, and operative data were examined for statistical association with postoperative seizure outcomes.
Results: Of the 66 patients who underwent surgical resection of ganglioglioma, 49 patients (74%) presented with a history of seizures. Of those 49 patients, 50% presented with intractable epilepsy. Temporal lobe gangliogliomas were present in 76% of the patients who presented with a history of seizures. Electrocorticography was performed on 35% of the patients, and of those patients, 82% underwent extended lesionectomy to remove abnormally epileptogenic extralesional tissue. The median follow-up duration was 6.9 years, during which tumor progression occurred in 38% of patients who underwent subtotal resection and in 8% of patients who underwent gross total resection (P = .02). Overall, 85% of patients were seizure free (International League Against Epilepsy class I or II) 5 years after surgery. Subtotal resection was associated with poor seizure outcomes 1 year after resection (odds ratio = 14.6; 95% confidence interval = 2.4-87.7): rates of seizure freedom were 54% after subtotal resection, 96% after gross total resection, and 93% after gross total resection with intraoperative electrocorticography-guided extended lesionectomy.
Conclusion: We report excellent long-term seizure control outcomes after surgery for gangliogliomas. Intraoperative electrocorticography may be a useful adjunct for guiding extended resection in certain pharmacoresistant epilepsy patients with gangliogliomas. Subtotal resection is associated with higher rates of tumor progression and nonoptimal seizure outcomes.
Similar articles
-
Seizure outcome with surgical management of epileptogenic ganglioglioma: a study of 55 patients.Acta Neurochir (Wien). 2012 May;154(5):855-61. doi: 10.1007/s00701-011-1259-z. Epub 2012 Jan 5. Acta Neurochir (Wien). 2012. PMID: 22218910
-
Pediatric epileptogenic gangliogliomas: seizure outcome and surgical results.J Neurosurg Pediatr. 2010 Mar;5(3):271-6. doi: 10.3171/2009.10.PEDS09372. J Neurosurg Pediatr. 2010. PMID: 20192644
-
Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients.J Neurosurg Pediatr. 2010 Jan;5(1):123-30. doi: 10.3171/2009.8.PEDS09368. J Neurosurg Pediatr. 2010. PMID: 20043747
-
Seizure Freedom Rates and Prognostic Indicators After Resection of Gangliogliomas: A Review.World Neurosurg. 2015 Dec;84(6):1988-96. doi: 10.1016/j.wneu.2015.06.044. Epub 2015 Jun 26. World Neurosurg. 2015. PMID: 26123501 Review.
-
Early surgical intervention in adult patients with ganglioglioma is associated with improved clinical seizure outcomes.J Clin Neurosci. 2011 Jan;18(1):29-33. doi: 10.1016/j.jocn.2010.05.002. Epub 2010 Oct 18. J Clin Neurosci. 2011. PMID: 20961765 Review.
Cited by
-
What is New in the Management of Epilepsy in Gliomas?Curr Treat Options Neurol. 2015 Jun;17(6):351. doi: 10.1007/s11940-015-0351-8. Curr Treat Options Neurol. 2015. PMID: 25912245
-
Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors.J Neurooncol. 2019 May;142(3):577-586. doi: 10.1007/s11060-019-03131-0. Epub 2019 Feb 25. J Neurooncol. 2019. PMID: 30805752
-
Seizure outcomes and prognostic factors in patients with gangliogliomas associated with epilepsy.Front Surg. 2022 Aug 11;9:946201. doi: 10.3389/fsurg.2022.946201. eCollection 2022. Front Surg. 2022. PMID: 36034348 Free PMC article.
-
Seizure prognosis in brain tumors: new insights and evidence-based management.Oncologist. 2014 Jul;19(7):751-9. doi: 10.1634/theoncologist.2014-0060. Epub 2014 Jun 4. Oncologist. 2014. PMID: 24899645 Free PMC article. Review.
-
DNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification.Neuropathol Appl Neurobiol. 2023 Apr;49(2):e12894. doi: 10.1111/nan.12894. Neuropathol Appl Neurobiol. 2023. PMID: 36843390 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical